Health written question – answered at on 21 January 2014.
To ask the Secretary of State for Health what steps his Department is taking to improve NHS treatment provision for patients with congenital adrenal hyperplasia.
NHS England is responsible for commissioning specialised services and improving NHS treatment provision for children and adults with congenital adrenal hyperplasia (CAH).
NHS England's ‘Paediatric Medicine: Endocrinology and Diabetes’ service specification sets out how the service should ensure access to high-quality treatment for endocrine disorders in children, including CAH, across England. Treatments offered include medical and surgical management of endocrine disease, nutritional and psychological support for the child and their family, educational support and counselling about preparation for treatment and prognosis. Many children with endocrine disease have a life-long chronic disease and therefore contact with the paediatric endocrine service will be extensive.
With regard to adults, NHS England's service specification for specialised endocrinological services, including CAH, makes it clear that one of the aims of the service is to provide and deliver access to high- quality medical and surgical treatment for patients with endocrinological conditions, including CAH, across England.
Service specifications clearly set out what providers need to have in place to offer evidence-based, safe and effective services.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.